NIH-funded research P01 program project

Investigating how vaccines can induce protective immunity against HIV

Official title: Core B: Non-human Primate Core

Funded at Univ of North Carolina Chapel Hill · NIH-11059122 · Data updated 2026-11-12

This study is looking at how to create a strong vaccine for HIV/AIDS by learning how certain antibodies are made in young monkeys, which could help us understand how to protect people from the virus for a long time.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJune 1, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$252,829
NIH project number5P01AI178377-03
Project IDNIH-11059122 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include infants and adults at risk for HIV infection.

Less likely to help

Patients who are already living with HIV/AIDS may not directly benefit from this research.

What this research studies

This research focuses on developing an effective vaccine for HIV/AIDS by studying how broadly neutralizing antibodies (bnAbs) can be induced. It utilizes non-human primates, specifically infant rhesus macaques, to explore the biological factors that influence B cell differentiation and the development of these antibodies. The research employs systems biology approaches to analyze immune responses and the role of the intestinal microbiome in vaccine effectiveness. By understanding these mechanisms, the goal is to create a vaccine that provides long-term protection against HIV.

Why it matters

Potential benefit: If successful, this research could lead to the development of a highly effective HIV vaccine, significantly reducing the incidence of HIV/AIDS.

How similar studies have gone: Previous research has shown promise in developing bnAbs in non-human primates, indicating potential success for this approach.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: De Paris, Kristina — Univ of North Carolina Chapel Hill
  • Study coordinator: De Paris, Kristina

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.